ORal IrON Supplementation With Ferric Maltol in Patients With Pulmonary Hypertension (ORION-PH-1)
Status:
Terminated
Trial end date:
2020-03-19
Target enrollment:
Participant gender:
Summary
This is an explorative, open-label, uncontrolled, single center study to explore the
preliminary safety, tolerability and efficacy of oral ferric maltol in treating iron
deficiency in patients with pulmonary hypertension and iron deficiency anemia.